Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.

BMC Cancer · 2023 · PMC9942407 · PMID 36810001

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

only marginally significantP = 0.051so close (0.05 < p ≤ 0.1)

Univariate Cox analysis demonstrated that HER2-positive patients had better BCSS than HER2-low patients (hazard ratio = 0.422, 95% confidence interval [CI] = 0.199–0.892, P = 0.024), while the survival difference between the HER2-zero and HER2-low groups was only marginally significant (HR = 1.797, 95% CI = 0.997–3.239, P = 0.051).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.